{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:09:58Z","timestamp":1757621398122,"version":"3.44.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Hope Run Special Fund","award":["no. LC2021B16"],"award-info":[{"award-number":["no. LC2021B16"]}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["Grant No. 2021-I2M-1-067"],"award-info":[{"award-number":["Grant No. 2021-I2M-1-067"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-MSDZD2022-0245"],"award-info":[{"award-number":["Y-MSDZD2022-0245"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2023-I2M-2-004"],"award-info":[{"award-number":["2023-I2M-2-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-025-04191-6","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T19:44:13Z","timestamp":1754077453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-expression (primitive enterocyte phenotype and neuroendocrine differentiation) gastric adenocarcinoma: the unique high-aggressive subtype"],"prefix":"10.1007","author":[{"given":"Bingzhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"1","key":"4191_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends\u2013an update. Cancer Epidemiol Biomarkers Prev 25(1):16\u201327","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"4191_CR2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/PAS.0000000000000869","volume":"41","author":"S Yamazawa","year":"2017","unstructured":"Yamazawa S, Ushiku T, Shinozaki-Ushiku A, Hayashi A, Iwasaki A, Abe H, Tagashira A, Yamashita H, Seto Y, Aburatani H et al (2017) Gastric cancer with primitive enterocyte phenotype: an aggressive subgroup of intestinal-type adenocarcinoma. Am J Surg Pathol 41(7):989\u2013997","journal-title":"Am J Surg Pathol"},{"issue":"28","key":"4191_CR3","first-page":"1277","volume":"78","author":"J Bourreille","year":"1970","unstructured":"Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A (1970) Existence of alpha feto protein during gastric-origin secondary cancer of the liver. Presse Med 78(28):1277\u20131278","journal-title":"Presse Med"},{"issue":"4","key":"4191_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/1097-0142(19850815)56:4<840::AID-CNCR2820560423>3.0.CO;2-E","volume":"56","author":"H Ishikura","year":"1985","unstructured":"Ishikura H, Fukasawa Y, Ogasawara K, Natori T, Tsukada Y, Aizawa M (1985) An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report. Cancer 56(4):840\u2013848","journal-title":"Cancer"},{"issue":"2","key":"4191_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s10120-015-0497-9","volume":"19","author":"T Murakami","year":"2016","unstructured":"Murakami T, Yao T, Mitomi H, Morimoto T, Ueyama H, Matsumoto K, Saito T, Osada T, Nagahara A, Watanabe S (2016) Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric Cancer 19(2):498\u2013507","journal-title":"Gastric Cancer"},{"issue":"9","key":"4191_CR6","first-page":"ED03","volume":"11","author":"A Lakshmanan","year":"2017","unstructured":"Lakshmanan A, Kurian A, Subramanyan A, Srinivasan A (2017) An alpha fetoprotein producing gastric tumor with yolk sac, hepatoid and papillary adenocarcinoma components. J Clin Diagn Res 11(9):ED03\u2013ED05","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"4191_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/PAS.0b013e31823aafec","volume":"36","author":"T Kinjo","year":"2012","unstructured":"Kinjo T, Taniguchi H, Kushima R, Sekine S, Oda I, Saka M, Gotoda T, Kinjo F, Fujita J, Shimoda T (2012) Histologic and immunohistochemical analyses of alpha-fetoprotein\u2013producing cancer of the stomach. Am J Surg Pathol 36(1):56\u201365","journal-title":"Am J Surg Pathol"},{"key":"4191_CR8","first-page":"201375","volume":"2012","author":"A Suzuki","year":"2012","unstructured":"Suzuki A, Koide N, Kitazawa M, Mochizuka A, Ota H, Miyagawa S (2012) Gastric composite tumor of alpha fetoprotein-producing carcinoma\/hepatoid adenocarcinoma and endocrine carcinoma with reference to cellular phenotypes. Patholog Res Int 2012:201375","journal-title":"Patholog Res Int"},{"issue":"1","key":"4191_CR9","first-page":"50","volume":"2","author":"B Wang","year":"2022","unstructured":"Wang B, Du C, Li L, Xie Y, Hu C, Li Z, Zhu Y, Yuan Y, Liu X, Lu N et al (2022) New substituted molecular classifications of advanced gastric adenocarcinoma: characteristics and probable treatment strategies. J Natl Cancer Cent 2(1):50\u201359","journal-title":"J Natl Cancer Cent"},{"issue":"4","key":"4191_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cjp2.53","volume":"2","author":"M Kobel","year":"2016","unstructured":"Kobel M, Piskorz AM, Lee S, Lui S, LePage C, Marass F, Rosenfeld N, Mes Masson AM, Brenton JD (2016) Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol Clin Res 2(4):247\u2013258","journal-title":"J Pathol Clin Res"},{"key":"4191_CR11","unstructured":"Cancer AJCo (2017) AJCC cancer staging manual, 8th edn: Springer Nature"},{"issue":"1","key":"4191_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41467-022-28437-y","volume":"13","author":"JH Cheong","year":"2022","unstructured":"Cheong JH, Wang SC, Park S, Porembka MR, Christie AL, Kim H, Kim HS, Zhu H, Hyung WJ, Noh SH et al (2022) Development and validation of a prognostic and predictive 32-gene signature for gastric cancer. Nat Commun 13(1):774","journal-title":"Nat Commun"},{"issue":"3","key":"4191_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1053\/j.gastro.2013.05.010","volume":"145","author":"Z Lei","year":"2013","unstructured":"Lei Z, Tan IB, Das K, Deng N, Zouridis H, Pattison S, Chua C, Feng Z, Guan YK, Ooi CH et al (2013) Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology 145(3):554\u2013565","journal-title":"Gastroenterology"},{"issue":"1","key":"4191_CR14","doi-asserted-by":"publisher","first-page":"12248","DOI":"10.1038\/s41598-018-30686-1","volume":"8","author":"VV Subhash","year":"2018","unstructured":"Subhash VV, Yeo MS, Wang L, Tan SH, Wong FY, Thuya WL, Tan WL, Peethala PC, Soe MY, Tan DSP et al (2018) Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor. Sci Rep 8(1):12248","journal-title":"Sci Rep"},{"issue":"8024","key":"4191_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-024-07698-1","volume":"632","author":"X Pan","year":"2024","unstructured":"Pan X, Li X, Dong L, Liu T, Zhang M, Zhang L, Zhang X, Huang L, Shi W, Sun H et al (2024) Tumour vasculature at single-cell resolution. Nature 632(8024):429\u2013436","journal-title":"Nature"},{"issue":"7","key":"4191_CR16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.ccell.2023.06.001","volume":"41","author":"J Griger","year":"2023","unstructured":"Griger J, Widholz SA, Jesinghaus M, de Andrade Kratzig N, Lange S, Engleitner T, Montero JJ, Zhigalova E, Ollinger R, Suresh V et al (2023) An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets. Cancer Cell 41(7):1327-1344 e1310","journal-title":"Cancer Cell"},{"issue":"23","key":"4191_CR17","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.3390\/cancers15235649","volume":"15","author":"H Wang","year":"2023","unstructured":"Wang H, Zhu Y, Sun W, Yang X, Liu X, Chi K, Huang X, Zhou L, Cai W, Lin D (2023) Clonality analysis for the relationship between the pulmonary combined neuroendocrine carcinoma and \u201cthe so-called reported histologic transformation.\u201d Cancers (Basel) 15(23):5649","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4191_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10120-024-01471-z","volume":"27","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Xie Y, Zhang W, Du C, Zhong Y, Zhu Y, Jiang L, Dou L, Shao K, Sun Y et al (2024) Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial. Gastric Cancer 27(3):571\u2013579","journal-title":"Gastric Cancer"},{"issue":"9","key":"4191_CR19","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1038\/s41379-021-00823-9","volume":"34","author":"S Ahn","year":"2021","unstructured":"Ahn S, Kim KM (2021) PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28\u20138 pharmDx assays for responses to immunotherapy. Mod Pathol 34(9):1719\u20131727","journal-title":"Mod Pathol"},{"issue":"1","key":"4191_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/PAI.0b013e3181b70594","volume":"18","author":"TC Martinsen","year":"2010","unstructured":"Martinsen TC, Skogaker NE, Fossmark R, Nordrum IS, Sandvik AK, Bendheim MO, Bakkelund KE, Waldum HL (2010) Neuroendocrine cells in diffuse gastric carcinomas: an ultrastructural study with immunogold labeling of chromogranin A. Appl Immunohistochem Mol Morphol 18(1):62\u201368","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"5","key":"4191_CR21","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1309\/AJCPM13KVNCZQBUV","volume":"137","author":"V Canzonieri","year":"2012","unstructured":"Canzonieri V, Colarossi C, Del Col L, Perin T, Talamini R, Sigon R, Cannizzaro R, Aiello E, Buonadonna A, Italia F et al (2012) Exocrine and endocrine modulation in common gastric carcinoma. Am J Clin Pathol 137(5):712\u2013721","journal-title":"Am J Clin Pathol"},{"key":"4191_CR22","unstructured":"Board WCoTE (2020) WHO classification of tumours: breast tumours, 5th edn. Lyon (France): International Agency for Research on Cancer"},{"issue":"3","key":"4191_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/his.12766","volume":"68","author":"G Bogina","year":"2016","unstructured":"Bogina G, Munari E, Brunelli M, Bortesi L, Marconi M, Sommaggio M, Lunardi G, Gori S, Massocco A, Pegoraro MC et al (2016) Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome. Histopathology 68(3):422\u2013432","journal-title":"Histopathology"},{"key":"4191_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.anndiagpath.2018.03.010","volume":"34","author":"C Kelten Talu","year":"2018","unstructured":"Kelten Talu C, Leblebici C, Kilicaslan Ozturk T, Hacihasanoglu E, Baykal Koca S, Gucin Z (2018) Primary breast carcinomas with neuroendocrine features: clinicopathological features and analysis of tumor growth patterns in 36 cases. Ann Diagn Pathol 34:122\u2013130","journal-title":"Ann Diagn Pathol"},{"key":"4191_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jocn.2016.06.004","volume":"34","author":"SS Guraya","year":"2016","unstructured":"Guraya SS, Prayson RA (2016) Metastatic prostatic adenocarcinoma with neuroendocrine differentiation to meningioma. J Clin Neurosci 34:30\u201332","journal-title":"J Clin Neurosci"},{"issue":"6","key":"4191_CR26","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/1097-0142(19880915)62:6<1096::AID-CNCR2820620612>3.0.CO;2-T","volume":"62","author":"A Ooi","year":"1988","unstructured":"Ooi A, Mai M, Ogino T, Ueda H, Kitamura T, Takahashi Y, Kawahara E, Nakanishi I (1988) Endocrine differentiation of gastric adenocarcinoma. The prevalence as evaluated by immunoreactive chromogranin A and its biologic significance. Cancer 62(6):1096\u20131104","journal-title":"Cancer"},{"issue":"4","key":"4191_CR27","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3748\/wjg.v9.i4.858","volume":"9","author":"GY Yao","year":"2003","unstructured":"Yao GY, Zhou JL, Lai MD, Chen XQ, Chen PH (2003) Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases. World J Gastroenterol 9(4):858\u2013861","journal-title":"World J Gastroenterol"},{"issue":"5","key":"4191_CR28","first-page":"7837","volume":"8","author":"T Zhang","year":"2015","unstructured":"Zhang T, Su D, Mao Z, Guo X, Wang L, Bai L (2015) Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma. Int J Clin Exp Med 8(5):7837\u20137842","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"4191_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5230\/jgc.2011.11.4.195","volume":"11","author":"JJ Kim","year":"2011","unstructured":"Kim JJ, Kim JY, Hur H, Cho YK, Han SU (2011) Clinicopathologic significance of gastric adenocarcinoma with neuroendocrine features. J Gastric Cancer 11(4):195\u2013199","journal-title":"J Gastric Cancer"},{"issue":"2","key":"4191_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s13691-015-0236-4","volume":"5","author":"Y Asahi","year":"2016","unstructured":"Asahi Y, Kamiyama T, Homma S, Hatanaka KC, Yokoo H, Nakagawa T, Kamachi H, Nakanishi K, Tahara M, Kakisaka T et al (2016) Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer-report of 4 cases. Int Cancer Conf J 5(2):98\u2013103","journal-title":"Int Cancer Conf J"},{"issue":"5","key":"4191_CR31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gut.32.5.542","volume":"32","author":"YC Chang","year":"1991","unstructured":"Chang YC, Nagasue N, Abe S, Kohno H, Kumar DD, Nakamura T (1991) alpha Fetoprotein producing early gastric cancer with liver metastasis: report of three cases. Gut 32(5):542\u2013545","journal-title":"Gut"},{"issue":"3","key":"4191_CR32","first-page":"321","volume":"87","author":"YC Chang","year":"1992","unstructured":"Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T (1992) Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 87(3):321\u2013325","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"4191_CR33","first-page":"151","volume":"57","author":"A Rodriguez-Villena","year":"2024","unstructured":"Rodriguez-Villena A, Veliz-Dominguez A, Gonzalez-Garcia I, Ruz-Caracuel I (2024) Enteroblastic adenocarcinoma of the ampulla of Vater. Rev Esp Patol 57(2):151\u2013155","journal-title":"Rev Esp Patol"},{"issue":"4","key":"4191_CR34","first-page":"370","volume":"53","author":"Q Wang","year":"2024","unstructured":"Wang Q, Zhang Y, Tan C, Ni SJ, Huang D, Chang B, Sheng WQ, Wang L (2024) Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases. Zhonghua Bing Li Xue Za Zhi 53(4):370\u2013376","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"9","key":"4191_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1023\/A:1004102312006","volume":"32","author":"G Qvigstad","year":"2000","unstructured":"Qvigstad G, Sandvik AK, Brenna E, Aase S, Waldum HL (2000) Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique. Histochem J 32(9):551\u2013556","journal-title":"Histochem J"},{"issue":"1","key":"4191_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5230\/jgc.2019.19.e9","volume":"19","author":"Y Zou","year":"2019","unstructured":"Zou Y, Chen L, Wang X, Chen Y, Hu L, Zeng S, Wang P, Li G, Huang M, Wang L et al (2019) Prognostic threshold of neuroendocrine differentiation in gastric carcinoma: a clinicopathological study of 945 cases. J Gastric Cancer 19(1):121\u2013131","journal-title":"J Gastric Cancer"},{"key":"4191_CR37","unstructured":"Board WCoTE (2019) WHO classification of tumours: digestive system tumours, 5th edn. Lyon (France): International Agency for Research on Cancer"},{"issue":"4","key":"4191_CR38","first-page":"919","volume":"22","author":"Y Bozkaya","year":"2017","unstructured":"Bozkaya Y, Ozdemir N, Colak A, Zengin N (2017) Gastric adenocarcinoma with neuroendocrine differentiation: clinicopathological features and efficacy of modified DCF chemotherapy. J BUON 22(4):919\u2013925","journal-title":"J BUON"},{"issue":"7","key":"4191_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/jclinpath-2017-204928","volume":"71","author":"M Fujimoto","year":"2018","unstructured":"Fujimoto M, Matsuzaki I, Nishino M, Iwahashi Y, Warigaya K, Kojima F, Ono K, Murata SI (2018) HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types. J Clin Pathol 71(7):600\u2013607","journal-title":"J Clin Pathol"},{"issue":"1","key":"4191_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3892\/ol.2017.6240","volume":"14","author":"Z Li","year":"2017","unstructured":"Li Z, Hou X, Chen J, Sun H, Mi Y, Sui Y, Li Y, Xie J, Qiao Y, Lei X et al (2017) Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancer. Oncol Lett 14(1):579\u2013586","journal-title":"Oncol Lett"},{"key":"4191_CR41","doi-asserted-by":"publisher","unstructured":"Wang B, Wang Y, Zhu Y, Guo L, Zeng H, Wu S, Wang L, Mu J, Shao X, Cheng N et al (2025) Predictive factors for neoadjuvant combined immunotherapy in gastric adenocarcinoma: focusing on the primitive enterocyte phenotype and PVR. Br J Cancer.\u00a0https:\/\/doi.org\/10.1038\/s41416-025-03031-3","DOI":"10.1038\/s41416-025-03031-3"},{"issue":"7","key":"4191_CR42","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.4161\/cbt.6.7.4253","volume":"6","author":"S Kamata","year":"2007","unstructured":"Kamata S, Kishimoto T, Kobayashi S, Miyazaki M, Ishikura H (2007) Possible involvement of persistent activity of the mammalian target of rapamycin pathway in the cisplatin resistance of AFP-producing gastric cancer cells. Cancer Biol Ther 6(7):1036\u20131043","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"4191_CR43","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/cas.12301","volume":"104","author":"L Zhao","year":"2013","unstructured":"Zhao L, Yasumoto K, Kawashima A, Nakagawa T, Takeuchi S, Yamada T, Matsumoto K, Yonekura K, Yoshie O, Yano S (2013) Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. Cancer Sci 104(12):1640\u20131646","journal-title":"Cancer Sci"},{"issue":"1","key":"4191_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF02893409","volume":"10","author":"F Eren","year":"2004","unstructured":"Eren F, Celikel C, Gulluoglu B (2004) Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53. Pathol Oncol Res 10(1):47\u201351","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"4191_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s004280100540","volume":"440","author":"KM Kim","year":"2002","unstructured":"Kim KM, Kim MJ, Cho BK, Choi SW, Rhyu MG (2002) Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas. Virchows Arch 440(1):85\u201393","journal-title":"Virchows Arch"},{"issue":"4","key":"4191_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000369071","volume":"100","author":"M Scardoni","year":"2014","unstructured":"Scardoni M, Vittoria E, Volante M, Rusev B, Bersani S, Mafficini A, Gottardi M, Giandomenico V, Malleo G, Butturini G et al (2014) Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components. Neuroendocrinology 100(4):310\u2013316","journal-title":"Neuroendocrinology"},{"key":"4191_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.humpath.2018.04.022","volume":"78","author":"Y Akazawa","year":"2018","unstructured":"Akazawa Y, Saito T, Hayashi T, Yanai Y, Tsuyama S, Akaike K, Suehara Y, Takahashi F, Takamochi K, Ueyama H et al (2018) Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. Hum Pathol 78:79\u201388","journal-title":"Hum Pathol"},{"issue":"5","key":"4191_CR48","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K et al (2015) Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 21(5):449\u2013456","journal-title":"Nat Med"},{"key":"4191_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.humpath.2019.03.005","volume":"88","author":"N Yatagai","year":"2019","unstructured":"Yatagai N, Saito T, Akazawa Y, Hayashi T, Yanai Y, Tsuyama S, Murakami T, Ueyama H, Watanabe S, Nagahara A et al (2019) Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation. Hum Pathol 88:18\u201326","journal-title":"Hum Pathol"},{"key":"4191_CR50","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2147\/CMAR.S187219","volume":"11","author":"D Chen","year":"2019","unstructured":"Chen D, Lin X, Zhang C, An G, Li Z, Dong B, Shen L, Gao J, Zhang X (2019) Activated Wnt signaling promotes growth and progression of AFP-producing gastric cancer in preclinical models. Cancer Manag Res 11:1349\u20131362","journal-title":"Cancer Manag Res"},{"issue":"22","key":"4191_CR51","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1200\/JCO.2011.34.9670","volume":"29","author":"Y Furuya","year":"2011","unstructured":"Furuya Y, Wakahara T, Akimoto H, Kishimoto T, Hiroshima K, Yanagie H, Yasuhara H (2011) Clear cell adenocarcinoma with enteroblastic differentiation of the ascending colon. J Clin Oncol 29(22):e647-649","journal-title":"J Clin Oncol"},{"issue":"4","key":"4191_CR52","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/pin.12402","volume":"66","author":"K Mitsuma","year":"2016","unstructured":"Mitsuma K, Taniguchi H, Kishi Y, Hiraoka N (2016) A case of adenocarcinoma with enteroblastic differentiation of the ampulla of Vater. Pathol Int 66(4):230\u2013235","journal-title":"Pathol Int"},{"key":"4191_CR53","first-page":"57","volume":"9","author":"LM Ricaurte","year":"2018","unstructured":"Ricaurte LM, Arrieta O, Zatarain-Barron ZL, Cardona AF (2018) Comprehensive review of fetal adenocarcinoma of the lung. Lung Cancer (Auckl) 9:57\u201363","journal-title":"Lung Cancer (Auckl)"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04191-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04191-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04191-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:50:05Z","timestamp":1757335805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04191-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":53,"alternative-id":["4191"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04191-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"type":"print","value":"0945-6317"},{"type":"electronic","value":"1432-2307"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the CICAMS ethics committee prior to commencing this study (No21\/105\u20132776). All methods were performed in accordance with the relevant guidelines and regulations, and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}